Becton, Dickinson and Company (BDX) News
Track canonical SquawkNews coverage tagged to BDX, Becton, Dickinson and Company. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 32 indexed stories across 22 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
BDX - Arthur Hu to Join BD as Chief Information and Digital Officer
BDX - Arthur Hu to Join BD as Chief Information and Digital Officer
NEWS | Sep 21, 2026, 08:30 PM UTC
L
BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
BCAL Diagnostics Ltd ASX:BDX
EQUITY | Sep 10, 2026, 07:52 AM UTC
L
BDX: Growth platforms drive strong results as headwinds ease and innovation accelerates
Management highlighted strong growth from focused platforms, ongoing margin expansion, and disciplined pricing. Key headwinds from Alaris, vaccines, and China are expected to ease, while innovation and capital allocation
GEOPOLITICS | Sep 09, 2026, 03:09 PM UTC
L
Budimex announces annulment of offer selection for bypass project
Budimex SA notified about annulment of offer selection for the design and construction of the Brzostek and Kołaczyce bypass.
EQUITY | Sep 07, 2026, 03:01 PM UTC
L
Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
EQUITY | Sep 02, 2026, 11:45 PM UTC
L
Becton Dickinson price target raised by B of A Securities
B of A Securities raised its Becton Dickinson price target to $200.00/share from $185.00.
EQUITY | Aug 31, 2026, 05:49 PM UTC
L
Budimex 195.5 million zloty offer selected in PSE tender
PSE selected Budimex’s 195.5 million zloty offer as the most favourable in a tender.
EQUITY | Aug 28, 2026, 03:21 PM UTC
L
BDX - BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
BDX - BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
EQUITY | Aug 27, 2026, 10:50 AM UTC
L
BDX - BD to Present at Wells Fargo 21st Annual Healthcare Conference
BDX - BD to Present at Wells Fargo 21st Annual Healthcare Conference
EQUITY | Aug 26, 2026, 08:15 PM UTC
L
BD to Present at Wells Fargo 21st Annual Healthcare Conference
BD to Present at Wells Fargo 21st Annual Healthcare Conference
EQUITY | Aug 26, 2026, 08:15 PM UTC
H
BDX: US FDA early alert flags high-risk issue in convenience kits
Becton Dickinson says the US FDA issued an early alert regarding a high-risk issue with its convenience kits and advises removing recalled components and avoiding sodium chloride ampules in affected kits.
REGULATION | Aug 18, 2026, 08:25 PM UTC
M
BDX appoints Gary Sorsher as Chief Quality Officer
BD appoints Gary Sorsher as Chief Quality Officer and names Jeff Silvestri to retire, according to TradeXchange Newsdesk.
REGULATION | Aug 17, 2026, 08:30 PM UTC
H
FDA alerts providers on Medline kits tied to BD recall
The FDA alerted healthcare providers about Medline convenience kits containing recalled Becton Dickinson antiseptic applicators, and Medline instructed customers to inspect and quarantine affected stock.
EARNINGS | Aug 13, 2026, 06:00 PM UTC
L
BDX - BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
BDX - BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
EQUITY | Aug 12, 2026, 10:50 AM UTC
H
Becton Dickinson Q3 Adjusted EPS Beats Estimates
Becton Dickinson reports Q3 adjusted EPS of $3.23
EARNINGS | Aug 06, 2026, 10:41 AM UTC
H
Becton Dickinson Raises FY2026 Adj EPS Guidance from $12.52-$12.72 to $12.62-$12.72 vs $12.61 Est
Becton Dickinson (NYSE: BDX ) raises FY2026 Adj EPS guidance from $12.52-$12.72 to $12.62-$12.72 vs $12.61 analyst estimate..
EARNINGS | Aug 06, 2026, 10:31 AM UTC
L
BDX - BD Reports Third Quarter Fiscal 2026 Financial Results
BDX - BD Reports Third Quarter Fiscal 2026 Financial Results
EQUITY | Aug 06, 2026, 10:30 AM UTC
M
BDX: Recall Does Not Affect Intraosseous Driver
BDX recall does not affect intraosseous driver
EQUITY | Jul 31, 2026, 06:32 PM UTC
H
BDX: 4 deaths reported from defective needle sets
BDX faces complaints over defective needle sets
EQUITY | Jul 31, 2026, 06:31 PM UTC
H
BDX Reports Stylet Removal Issues
BDX reports 4 deaths due to stylet removal issues
EQUITY | Jul 31, 2026, 06:30 PM UTC
H
BDX Recalls Vascular Access System Needle Sets
BDX recalls needle sets due to difficulty removing obturator
EQUITY | Jul 31, 2026, 06:30 PM UTC
H
BDX launches semaglutide in Brazil
BDX expands GLP-1 therapies in Brazil
EQUITY | Jul 29, 2026, 10:55 AM UTC
H
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled. Top 5 Upgrades: UBS upgraded Intuitive Surgical (I
EARNINGS | Jul 28, 2026, 01:35 PM UTC
L
BDX new Buy W/ $190 PT @ UBS
BDX new Buy W/ $190 PT @ UBS
EQUITY | Jul 28, 2026, 12:43 PM UTC
L
BDX Initiated Buy W/$190.00 PT at UBS
BDX Initiated Buy W/$190.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: O
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: OUTPERFORM @ Wedbush CRWD: BUY @ Loop FTH: OUTPERFORM @ Opp HRB: EQUAL WEIGHT @ S
EQUITY | Jul 28, 2026, 11:11 AM UTC
L
Near 200dma support AWK NI NEE BDX FAST BLK PG WAL ITT MCK WTRG BRKB ATO DKS
Near 200dma support AWK NI NEE BDX FAST BLK PG WAL ITT MCK WTRG BRKB ATO DKS
EQUITY | Jul 20, 2026, 04:42 PM UTC
L
Outperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - BKNG +2.50%, RCL +2.37%, TPR +2.29%, AMZN +1.89%, ROST +1.53%
Outperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - BKNG +2.50%, RCL +2.37%, TPR +2.29%, AMZN +1.89%, ROST +1.53% Consumer Staples (XLP) - TGT +2.73%, CLX +2.53%, DLTR +2.24%, PM +1.82%, EL +1.
RATES | Jul 15, 2026, 06:23 PM UTC
L
BDX REGN SJM session highs
BDX REGN SJM session highs
EQUITY | Jul 14, 2026, 05:13 PM UTC
L
BDX Price Target Alert: $180.00. Issued by Evercore ISI
2026-07-06 10:15:13 ET from Evercore ISI issued a price target of $180.00 for BDX on 2026-07-06 12:40:26. <
EQUITY | Jul 06, 2026, 02:15 PM UTC
L
Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190
() -- Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $172.55, according to analysts polled by FactSet. ( covers equity, commodity and economic research from major banks a
EQUITY | Jul 06, 2026, 01:21 PM UTC
L
BDX Awarded Contract
BDX awarded Vizient Innovative Technology Contract for CentroVena One Insertion System
EQUITY | Jun 23, 2026, 10:51 AM UTC